10 Results for "

rat ovarian aromatase

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "rat ovarian aromatase" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-13632
CAS No.: 107868-30-4
Purity:  99.83%
Synonyms: FCE 24304; EXE
Target:  

Cytochrome P450

Research Areas:  

Endocrinology Cancer

Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-13632R
CAS No.: 107868-30-4
Purity:  99.63%
Synonyms: FCE 24304(Standard); EXE (Standard)
Research Areas:  

Endocrinology Cancer

Exemestane (Standard) is the analytical standard of Exemestane. This product is intended for research and analytical applications. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-123247
CAS No.: 112959-07-6
Target:  

Cytochrome P450

Research Areas:  

Endocrinology

LY113174 is an orally active aromatase inhibitor (IC50 = 24 nM). LY113174 blocks testosterone induced increase in uterine weight in rat, and inhibits ovarian estrogen biosynthesis .
loading...
    loading...
Cat. No.: HY-13632S
Synonyms: FCE 24304-d2; EXE-d2
Exemestane-d2 is the deuterium labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-13632S2
Synonyms: FCE 24304-d3; EXE-d3
Exemestane-d3 is the deuterium labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-13632S1
CAS No.: 1092371-24-8
Synonyms: FCE 24304-13C3; EXE-13C3
Exemestane- 13C3 is the 13C-labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-13632S6
Synonyms: FCE 24304-d4; EXE-d4
Exemestane-d4 (FCE 24304-d4) is deuterium labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-13632S5
Synonyms: FCE 24304-13C,d2; EXE-13C,d2
Exemestane- 13C,d2 is 13C and deuterated labeled Exemestane (HY-13632). Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research .
loading...
    loading...
Cat. No.: HY-W393057
CAS No.: 57288-03-6
Target:  

Cytochrome P450

Research Areas:  

Cancer

(S)-Aminoglutethimide is an aromatase inhibitor. (S)-Aminoglutethimide has an IC50 value of 23.15 μM for rat ovarian microsomal aromatase. (S)-Aminoglutethimide can be used in the research of diseases such as breast cancer .
loading...
    loading...
Cat. No.: HY-123500
CAS No.: 134520-88-0
Target:  

Cytochrome P450

Research Areas:  

Cancer

CGP-45688 is an orally active non-steroidal aromatase inhibitor with an ED50 of 30-100 μg/kg. CGP-45688 can reduce the level of estrogen in the body, thereby inhibiting the growth of estrogen-dependent tumors. CGP-45688 inhibits the growth of estrogen-dependent breast tumors in rat models. CGP-45688 disrupts the ovarian cycle and inhibits the weight of the uterus. CGP-45688 can be used for the study of breast cancer .
loading...
    loading...